|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
177,680,000 |
Market
Cap: |
8.35(B) |
Last
Volume: |
3,979,543 |
Avg
Vol: |
1,940,342 |
52
Week Range: |
$50.38 - $99.04 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 568 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Exact Sciences is a cancer screening and diagnostics company. Co.'s primary screening product, the Cologuard® test, is a non-invasive stool-based DNA screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. Co.'s portfolio of Oncotype tests include: Oncotype DX gene expression tests for breast, prostate and colon cancers; Oncotype DX AR-V7 Nucleus Detect® test, a liquid-based test for advanced stage prostate cancer; and Oncotype MAP Pan-Cancer Tissue test (oncomap test), a test delivering tumor profiling to aid therapy selection for patients with metastatic, refractory or recurrent cancer.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
33,920 |
108,398 |
166,494 |
290,334 |
Total Sell Value |
$2,062,221 |
$6,570,910 |
$11,277,891 |
$18,676,003 |
Total People Sold |
10 |
10 |
11 |
11 |
Total Sell Transactions |
20 |
52 |
61 |
100 |
End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Coward D Scott |
Chief Administrative Officer |
|
2021-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,972 |
5,273 |
|
- |
|
Condella Sarah |
SVP, Human Resources |
|
2021-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,030 |
69,737 |
|
- |
|
Conroy Kevin T |
President and CEO |
|
2021-02-05 |
4 |
OE |
$5.70 |
$99,995 |
D/D |
17,543 |
777,153 |
|
- |
|
Conroy Kevin T |
President and CEO |
|
2021-02-01 |
4 |
AS |
$138.07 |
$4,189,596 |
D/D |
(30,344) |
759,610 |
|
-12% |
|
Conroy Kevin T |
President and CEO |
|
2021-01-04 |
4 |
AS |
$128.74 |
$4,095,734 |
D/D |
(31,814) |
825,704 |
|
-27% |
|
Coward D Scott |
Chief Administrative OfficerOf |
|
2020-12-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,073 |
|
-28% |
|
Coward D Scott |
Chief Administrative OfficerOf |
|
2020-12-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,301 |
|
-28% |
|
Lidgard Graham Peter |
Chief Science OfficerOfficer |
|
2020-12-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
17,398 |
|
-28% |
|
Lidgard Graham Peter |
Chief Science OfficerOfficer |
|
2020-12-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
33,755 |
|
-28% |
|
Condella Sarah |
SVP, Human ResourcesOfficer |
|
2020-12-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,801 |
|
-28% |
|
Condella Sarah |
SVP, Human ResourcesOfficer |
|
2020-12-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
67,707 |
|
-28% |
|
Conroy Kevin T |
President and CEO |
|
2020-12-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
35,750 |
789,954 |
|
- |
|
Napier Katherine S |
Director |
|
2020-12-14 |
4 |
AS |
$130.44 |
$2,641,182 |
D/D |
(20,000) |
21,907 |
|
7% |
|
Conroy Kevin T |
President and CEO |
|
2020-12-01 |
4 |
AS |
$122.05 |
$3,808,660 |
D/D |
(30,577) |
857,518 |
|
4% |
|
Conroy Kevin T |
President and CEO |
|
2020-11-02 |
4 |
AS |
$118.32 |
$3,974,738 |
D/D |
(32,819) |
888,095 |
|
6% |
|
Carey Thomas D. |
Director |
|
2020-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
420 |
22,292 |
|
- |
|
Sebelius Kathleen |
Director |
|
2020-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
420 |
11,178 |
|
- |
|
Jacquet Pierre |
Director |
|
2020-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
420 |
9,154 |
|
- |
|
Conroy Kevin T |
President and CEO |
|
2020-10-01 |
4 |
AS |
$102.86 |
$2,839,829 |
D/D |
(27,425) |
920,914 |
|
39% |
|
Hoof Torsten |
General Manager, International |
|
2020-09-24 |
4 |
S |
$80.00 |
$352,080 |
D/D |
(4,401) |
2,017 |
|
-53% |
|
Hoof Torsten |
General Manager, International |
|
2020-09-24 |
4 |
OE |
$41.53 |
$182,774 |
D/D |
4,401 |
6,418 |
|
- |
|
Conroy Kevin T |
President and CEO |
|
2020-09-01 |
4 |
AS |
$75.03 |
$1,495,123 |
D/D |
(19,927) |
948,339 |
|
97% |
|
Hoof Torsten |
General Manager, International |
|
2020-08-19 |
4 |
AS |
$84.90 |
$676,144 |
D/D |
(7,964) |
2,017 |
|
62% |
|
Hoof Torsten |
General Manager, International |
|
2020-08-19 |
4 |
OE |
$43.40 |
$65,794 |
D/D |
1,516 |
9,981 |
|
- |
|
Hoof Torsten |
General Manager, International |
|
2020-08-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,551 |
8,465 |
|
- |
|
777 Records found
|
|
Page 14 of 32 |
|
|